L364-0220 Screening compound: 4-(1-methyl-5-{[(1,3,5-trimethyl-1H-pyrazol-4-yl)sulfonyl]amino}-1H-1,3-benzimidazol-2-yl)-N~1~-propylbenzamide

L364-0220 Screening compound: 4-(1-methyl-5-{[(1,3,5-trimethyl-1H-pyrazol-4-yl)sulfonyl]amino}-1H-1,3-benzimidazol-2-yl)-N~1~-propylbenzamide
L364-0220 Screening compound: 4-(1-methyl-5-{[(1,3,5-trimethyl-1H-pyrazol-4-yl)sulfonyl]amino}-1H-1,3-benzimidazol-2-yl)-N~1~-propylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L364-0220
4-(1-methyl-5-{[(1,3,5-trimethyl-1H-pyrazol-4-yl)sulfonyl]amino}-1H-1,3-benzimidazol-2-yl)-N~1~-propylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L364-0220

Molecular Formula

C24H28N6O3S (C24 H28 N6 O3 S)

Compound Name

4-(1-methyl-5-{[(1,3,5-trimethyl-1H-pyrazol-4-yl)sulfonyl]amino}-1H-1,3-benzimidazol-2-yl)-N~1~-propylbenzamide

IUPAC name

n/a

SMILES

CCCNC(c(cc1)ccc1-c1nc(cc(cc2)NS(c3c(C)n(C)nc3C)(=O)=O)c2n1C)=O

InChI

InChI=1S/C24H28N6O3S/c1-6-13-25-24(31)18-9-7-17(8-10-18)23-26-20-14-19(11-12-21(20)29(23)4)28-34(32,33)22-15(2)27-30(5)16(22)3/h7-12,14,28H,6,13H2,1-5H3,(H,25,31)

InChI Key

SUASRDGZLGCWQM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27247885

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

480.59

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.596

Distribution Coefficient, logD

2.582

Water Solubility, LogSw

-3.12

Polar Surface Area

90.992

Acid Dissociation Constant (pKa)

8.99

Base Dissociation Constant (pKb)

5.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.20

L364-0220 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Immunological Library (6760 compounds)

Targeted Diversity Library (40567 compounds)

PD-1/L1 Library (498 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Immune system
  • Cancer
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Others

References: we are preparing a list of scientific research reports with L364-0220 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L364-0220?
Check Price and Availability of L364-0220, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L364-0220 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L364-0220
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L364-0220
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L364-0220 available by request